Neuland Laboratories Ltd - IndiaOne Finance

Overview (18 Sep 2026)

Neuland Laboratories Ltd

NEULANDLAB

INE794A01010

Pharmaceuticals
Result was last declared on 12 May 2026

175

Prev. Close

Previous Close

22665

Current Close

22840

Current High

23030

Current Low

22440

52 Week High

24225

52 Week Low

11500

Resistance 1

23100.00

Resistance 2

23360.00

Support 1

22510.00

Support 2

21920.00

Std Deviation

7.07%

DMA 200

16709.08

DMA 50

21522.84

DMA 20

23073.65

Fundamentals and Ratios

Standalone

Trailing EPS

283.01

Forwad EPS

416.01

Trailing P/E

80.7

Forward P/E

54.9

PEG Ratio

1.60

Mkt. Cap (Cr)

Market Cap (Cr)

29303.47

Total Debt(Cr)

Tot. Debt(Cr)

196.62

Reserve (Cr)

1861.57

Book Value

1464.43

P/BV Ratio

15.6

ROCE(%)

34.00

ROE

37.00

Consolidated

Trailing EPS

283.71

Forwad EPS

416.64

Trailing P/E

80.5

Forward P/E

54.82

PEG Ratio

1.60

Mkt. Cap (Cr)

Market Cap (Cr)

29303.47

Total Debt(Cr)

Tot. Debt(Cr)

211.62

Reserve (Cr)

1861.57

Book Value

1464.43

P/BV Ratio

15.60

ROCE(%)

33.34

ROE

26.5500

Financial Result

Standalone

Type	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	641.58	776.25	439.71	514.27	292.75	2022.99
Other Income	8.49	12.46	8.05	1.80	7.86	30.16
Total Income	650.07	788.71	447.76	516.07	300.61	2053.15
Interest	6.97	7.23	6.79	5.34	4.58	23.95
Expenditure	-452.53	-501.66	-393.49	-387.03	-283.23	-1565.42
PBDT	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	-26.56	-25.09	-23.92	-22.54	-20.19	-91.73
PBT	197.54	287.04	54.27	129.04	17.38	487.73
Tax	-50.17	-74.52	-13.86	-32.58	-3.67	-124.63
Equity	12.90	12.90	12.90	0.00	12.90	12.90
OPM	30.39	36.39	12.12	25.09	5.78	23.76
Net Profit	147.36	212.52	40.42	96.46	13.71	363.11
NPM	22.67	26.95	9.03	18.76	4.56	17.69
EPS	114.86	165.65	31.5	75.18	10.68	283.01

Consolidated

Type	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	641.58	776.25	439.71	514.27	292.75	2022.99
Other Income	8.49	12.46	8.05	1.80	7.86	30.17
Total Income	650.07	788.71	447.76	516.07	300.61	2053.15
Interest	6.97	7.21	6.79	5.37	4.58	23.95
Expenditure	-452.22	-501.21	-393.29	-386.64	-283.04	-1564.17
PBDT	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	-26.56	-25.09	-23.92	-22.54	-20.19	-91.74
PBT	197.85	287.49	54.48	129.44	17.57	488.98
Tax	-50.17	-74.82	-13.90	-32.58	-3.67	-124.98
Equity	12.90	12.90	0.00	0.00	12.90	12.90
OPM	30.44	36.45	12.17	25.08	5.84	23.82
Net Profit	147.67	212.67	40.57	96.85	13.9	364
NPM	22.72	26.96	9.06	18.77	4.62	17.73
EPS	115.1	165.76	31.62	75.49	10.83	283.71

Annual Reports

Corporate Action

Quarterly Result

Dividend

Year	Dividend Type	Amount	Remark	Ex Date
2026	Final Dividend	34.00	Final Dividend - Rs. - 34.0000	24 Jul 2026
2025	Final Dividend	12.00	Final Dividend - Rs. - 12.0000	18 Jul 2025
2024	Final Dividend	14.00	Final Dividend - Rs. - 14.0000	12 Jul 2024
2023	Final Dividend	10.00	Final Dividend - Rs. - 10.0000	11 Jul 2023
2022	Final Dividend	5.00	Final Dividend - Rs. - 5.0000	14 Jul 2022
2021	Final Dividend	3.00	Final Dividend - Rs. - 3.0000	29 Jun 2021
2021	Interim Divvidend	2.00	Interim Dividend - Rs. - 2.0000	10 Nov 2020
2020	Interim Divvidend	2.00	Interim Dividend - Rs. - 2.0000	18 Feb 2020
2019	Final Dividend	1.20	Dividend - Rs. - 1.2000	27 Jun 2019
2016	Final Dividend	2.00	Dividend - Rs. - 2.0000	04 Aug 2016
2015	Final Dividend	1.50	Dividend - Rs. - 1.5000	06 Aug 2015
2014	Final Dividend	1.50	Dividend - Rs. - 1.5000	16 Jun 2014
2014	Special Dividend	1.50	Special Dividend - Rs. - 1.5000	16 Jun 2014
2013	Final Dividend	1.20	Dividend - Rs. - 1.2000	24 Jul 2013
2009	Final Dividend	3.50	Dividend - Rs. - 3.5000	13 Jul 2009
2008	Final Dividend	2.50	Dividend - Rs. - 2.5000	17 Jul 2008

Bonus

Split

Mutual Fund Holddings

Sector peers

Sector: Pharmaceuticals

Company

Current Close

P/E Ratio

1837.3

148.17

9375

84.62

4840

78.80

1160

33.21

1394.5

36.64

1954

120.92

1734

38.79

1185

148.68

2083

13.69

2300.7

43.55

1